Blood microvesicles: From proteomics to physiology

Translational Proteomics

Volumn 1, Issue 1, 2013, Pages 38-52

  Tissot, Jean Daniel ^a   Canellini, Giorgia ^a   Rubin, Olivier ^a   Angelillo Scherrer, Anne ^b   Delobel, Julien ^a   Prudent, Michel ^a   Lion, Niels ^a  

^a Service Regional Vaudois de Transfusion Sanguine   (Switzerland)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Aging; Blood cells; Exosomes; Microparticles; Microvesicles; Proteomics

Indexed keywords

BLOOD CELL; CELL FUNCTION; CELL ISOLATION; CELL VACUOLE; ENDOTHELIUM CELL; ERYTHROCYTE; EXOSOME; FUNCTIONAL PROTEOMICS; HEMOSTASIS; HUMAN; LEUKOCYTE; PARTICLE SIZE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CONTENT; PURIFICATION; QUANTITATIVE STUDY; REVIEW; THROMBOCYTE;

EID: 84994442762     PISSN: 22129626     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trprot.2013.04.004     Document Type: Review

References (167)

1. Thadikkaran L., Siegenthaler M.A., Crettaz D., Queloz P.A., Schneider P., Tissot J.D. Recent advances in blood-related proteomics. Proteomics 2005, 5:3019-3034.
2. Lion N., Tissot J.D. Application of proteomics to hematology: the revolution is starting. Expert Review of Proteomics 2008, 5:375-379.
3. Tissot J.D. Blood proteomics. Journal of Proteomics 2010, 73:466-467.
4. Lion N., Crettaz D., Rubin O., Tissot J.D. Stored red blood cells: a changing universe waiting for its map(s). Journal of Proteomics 2010, 73:374-385.
5. Prudent M., Crettaz D., Delobel J., Tissot J.D., Lion N. Proteomic analysis of intercept-treated platelets. Journal of Proteomics 2012, 76:316-328.
6. Liumbruno G., D'Alessandro A., Grazzini G., Zolla L. How has proteomics informed transfusion biology so far?. Critical Reviews in Oncology/Hematology 2010, 76:153-172.
7. Liumbruno G., D'Alessandro A., Grazzini G., Zolla L. Blood-related proteomics. Journal of Proteomics 2010, 73:483-507.
8. Cluitmans J.C., Hardeman M.R., Dinkla S., Brock R., Bosman G.J. Red blood cell deformability during storage: towards functional proteomics and metabolomics in the Blood Bank. Blood Transfusion 2012, 10(Suppl. 2):s12-s18.
9. Hess J.R. Red cell storage. Journal of Proteomics 2010, 73:368-373.
10. Hess J.R., Grazzini G. Blood proteomics and transfusion safety. Journal of Proteomics 2010, 73:365-367.
11. Lion N., Prudent M., Crettaz D., Tissot J.D. Proteomics and transfusion medicine. Transfusion Clinique et Biologique 2011, 18:79-96.
12. Ray S., Reddy P.J., Jain R., Gollapalli K., Moiyadi A., Srivastava S. Proteomic technologies for the identification of disease biomarkers in serum: advances and challenges ahead. Proteomics 2011, 11:2139-2161.
13. Hanash S., Taguchi A. Application of proteomics to cancer early detection. Cancer Journal 2011, 17:423-428.
14. Taguchi A., Hanash S.M. Unleashing the power of proteomics to develop blood-based cancer markers. Clinical Chemistry 2013, 59:119-126.
15. Brambilla F., Lavatelli F., Di Silvestre D., Valentini V., Rossi R., Palladini G., et al. Reliable typing of systemic amyloidoses through proteomic analysis of subcutaneous adipose tissue. Blood 2012, 119:1844-1847.
16. Brambilla F., Lavatelli F., Merlini G., Mauri P. Clinical proteomics for diagnosis and typing of systemic amyloidoses. Proteomics, Clinical Applications 2013, 7:136-143.
17. Gyorgy B., Szabo T.G., Pasztoi M., Pal Z., Misjak P., Aradi B., et al. Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles. Cellular and Molecular Life Sciences 2011, 68:2667-2688.
18. Mathivanan S., Ji H., Simpson R.J. Exosomes: extracellular organelles important in intercellular communication. Journal of Proteomics 2010, 73:1907-1920.
19. Mause S.F., Weber C., Microparticles: protagonists of a novel communication network for intercellular information exchange. Circulation Research 2010, 107:1047-1057.
20. Diamant M., Tushuizen M.E., Sturk A., Nieuwland R. Cellular microparticles: new players in the field of vascular disease?. European Journal of Clinical Investigation 2004, 34:392-401.
21. Tissot J.D., Rubin O., Canellini G. Analysis and clinical relevance of microparticles from red blood cells. Current Opinion in Hematology 2010, 17:571-577.
22. Rubin O., Canellini G., Delobel J., Lion N., Tissot J.D. Red blood cell micropartilces: clinical relevance. Transfusion Medicine and Hemotherapy 2012, 39:342-347.
23. Simak J., Gelderman M.P. Cell membrane microparticles in blood and blood products: potentially pathogenic agents and diagnostic markers. Transfusion Medicine Reviews 2006, 20:1-26.
24. Morel O., Toti F., Hugel B., Bakouboula B., Camoin-Jau L., Dignat-George F., et al. Procoagulant microparticles: disrupting the vascular homeostasis equation?. Arteriosclerosis, Thrombosis, and Vascular Biology 2006, 26:2594-2604.
25. Hugel B., Martinez M.C., Kunzelmann C., Freyssinet J.M. Membrane microparticles: two sides of the coin. Physiology 2005, 20:22-27.
26. Wolf P. The nature and significance of platelet products in human plasma. British Journal of Haematology 1967, 13:269-288.
27. Greenwalt T.J. The how and why of exocytic vesicles. Transfusion 2006, 46:143-152.
28. Rubin O., Delobel J., Prudent M., Lion N., Kohl K., Tucker E.I., et al. Red blood cell-derived microparticles isolated from blood units initiate and propagate thrombin generation. Transfusion 2013, [in press].
29. Schifferli J.A. Microvesicles are messengers. Seminars in Immunopathology 2011, 33:393-394.
30. Sadallah S., Eken C., Schifferli J.A. Ectosomes as immunomodulators. Seminars in Immunopathology 2011, 33:487-495.
31. Sadallah S., Eken C., Schifferli J.A. Ectosomes as modulators of inflammation and immunity. Clinical and Experimental Immunology 2011, 163:26-32.
32. Shet A.S. Characterizing blood microparticles: technical aspects and challenges. Journal of Vascular Health and Risk Management 2008, 4:769-774.
33. Heijnen H.F., Schiel A.E., Fijnheer R., Geuze H.J., Sixma J.J. Activated platelets release two types of membrane vesicles: microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alpha-granules. Blood 1999, 94:3791-3799.
34. Aras O., Shet A., Bach R.R., Hysjulien J.L., Slungaard A., Hebbel R.P., et al. Induction of microparticle- and cell-associated intravascular tissue factor in human endotoxemia. Blood 2004, 103:4545-4553.
35. Mallat Z., Hugel B., Ohan J., Leseche G., Freyssinet J.M., Tedgui A. Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques: a role for apoptosis in plaque thrombogenicity. Circulation 1999, 99:348-353.
36. Aupeix K., Hugel B., Martin T., Bischoff P., Lill H., Pasquali J.L., et al. The significance of shed membrane particles during programmed cell death in vitro, and in vivo, in HIV-1 infection. Journal of Clinical Investigation 1997, 99:1546-1554.
37. Mallat Z., Benamer H., Hugel B., Benessiano J., Steg P.G., Freyssinet J.M., et al. Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes. Circulation 2000, 101:841-843.
38. Maurer-Spurej E., Labrie A., Pittendreigh C., Chipperfield K., Smith C., Heddle N., et al. Platelet quality measured with dynamic light scattering correlates with transfusion outcome in hematologic malignancies. Transfusion 2009, 49:2276-2284.
39. Xu Y., Nakane N., Maurer-Spurej E. Novel test for microparticles in platelet-rich plasma and platelet concentrates using dynamic light scattering. Transfusion 2011, 51:363-370.
40. Mrvar-Brecko A., Sustar V., Jansa V., Stukelj R., Jansa R., Mujagic E., et al. Isolated microvesicles from peripheral blood and body fluids as observed by scanning electron microscope. Blood Cells, Molecules, and Diseases 2010, 44:307-312.
41. Canellini G., Rubin O., Delobel J., Crettaz D., Lion N., Tissot J.D. Red blood cell microparticles and blood group antigens: an analysis by flow cytometry. Blood Transfusion 2012, 10(Suppl 2):s39-s45.
42. Gyorgy B., Szabo T.G., Turiak L., Wright M., Herczeg P., Ledeczi Z., et al. Improved flow cytometric assessment reveals distinct microvesicle (cell-derived microparticle) signatures in joint diseases. PLoS ONE 2012, 7:e49726.
43. Montoro-Garcia S., Shantsila E., Orenes-Pinero E., Lozano M.L., Lip G.Y. An innovative flow cytometric approach for small-size platelet microparticles: influence of calcium. Thrombosis and Haemostasis 2012, 108:373-383.
44. Yuana Y., Bertina R.M., Osanto S. Pre-analytical and analytical issues in the analysis of blood microparticles. Thrombosis and Haemostasis 2011, 105:396-408.
45. Rubin O., Crettaz D., Tissot J.D., Lion N. Pre-analytical and methodological challenges in red blood cell microparticle proteomics. Talanta 2010, 82:1-8.
46. Delobel J., Rubin O., Prudent M., Crettaz D., Tissot J.D., Lion N. Biomarker analysis of stored blood products: emphasis on pre-analytical issues. International Journal of Molecular Sciences 2010, 11:4601-4617.
47. Mullier F., Bailly N., Chatelain C., Chatelain B., Dogne J.M. Pre-analytical issues in the measurement of circulating microparticles: current recommendations and pending questions. Journal of Thrombosis and Haemostasis 2013, 11:693-696.
48. Xiong Z., Oriss T.B., Cavaretta J.P., Rosengart M.R., Lee J.S. Red cell microparticle enumeration: validation of a flow cytometric approach. Vox Sanguinis 2012, 103:42-48.
49. Leong H.S., Podor T.J., Manocha B., Lewis J.D. Validation of flow cytometric detection of platelet microparticles and liposomes by atomic force microscopy. Journal of Thrombosis and Haemostasis 2011, 9:2466-2476.
50. Chandler W.L. Microparticle counts in platelet-rich and platelet-free plasma, effect of centrifugation and sample-processing protocols. Blood Coagulation and Fibrinolysis 2013, 24:125-132.
51. Strasser E.F., Happ S., Weiss D.R., Pfeiffer A., Zimmermann R., Eckstein R. Microparticle detection in platelet products by three different methods. Transfusion 2013, 53:156-166.
52. Dragovic R.A., Gardiner C., Brooks A.S., Tannetta D.S., Ferguson D.J., Hole P., et al. Sizing and phenotyping of cellular vesicles using Nanoparticle Tracking Analysis. Nanomedicine 2011, 7:780-788.
53. Redman C.W., Tannetta D.S., Dragovic R.A., Gardiner C., Southcombe J.H., Collett G.P., et al. Review: does size matter? Placental debris and the pathophysiology of pre-eclampsia. Placenta 2012, 33(Suppl.):S48-S54.
54. Bosman G.J., Lasonder E., Groenen-Dopp Y.A., Willekens F.L., Werre J.M. The proteome of erythrocyte-derived microparticles from plasma: new clues for erythrocyte aging and vesiculation. Journal of Proteomics 2012, 76. [Spec No.: 203-10].
55. Simpson R.J., Lim J.W., Moritz R.L., Mathivanan S. Exosomes: proteomic insights and diagnostic potential. Expert Review of Proteomics 2009, 6:267-283.
56. Choi D.S., Kim D.K., Kim Y.K., Gho Y.S. Proteomics, transcriptomics and lipidomics of exosomes and ectosomes. Proteomics 2013, [in press].
57. Kim H.S., Choi D.Y., Yun S.J., Choi S.M., Kang J.W., Jung J.W., et al. Proteomic analysis of microvesicles derived from human mesenchymal stem cells. Journal of Proteome Research 2012, 11:839-849.
58. Epple L.M., Griffiths S.G., Dechkovskaia A.M., Dusto N.L., White J., Ouellette R.J., et al. Medulloblastoma exosome proteomics yield functional roles for extracellular vesicles. PLoS ONE 2012, 7:e42064.
59. Xiao D., Ohlendorf J., Chen Y., Taylor D.D., Rai S.N., Waigel S., et al. Identifying mRNA, microRNA and protein profiles of melanoma exosomes. PLoS ONE 2012, 7:e46874.
60. Choi D.S., Park J.O., Jang S.C., Yoon Y.J., Jung J.W., Choi D.Y., et al. Proteomic analysis of microvesicles derived from human colorectal cancer ascites. Proteomics 2011, 11:2745-2751.
61. Li M., Aliotta J.M., Asara J.M., Tucker L., Quesenberry P., Lally M., et al. Quantitative proteomic analysis of exosomes from HIV-1-infected lymphocytic cells. Proteomics 2012, 12:2203-2211.
62. Dear J.W., Street J.M., Bailey MA Urinary exosomes: a reservoir for biomarker discovery and potential mediators of intra-renal signaling. Proteomics 2013, [in press].
63. Santucci L., Candiano G., Bruschi M., Bodria M., Murtas C., Petretto A., et al. Urinary proteome in a snapshot: normal urine and glomerulonephritis. Journal of Nephrology 2013, [in press]. 10.5301/jn.5000233.
64. Keller S., Ridinger J., Rupp A.K., Janssen J.W., Altevogt P. Body fluid derived exosomes as a novel template for clinical diagnostics. Journal of Translational Medicine 2011, 9:86.
65. Street J.M., Barran P.E., Mackay C.L., Weidt S., Balmforth C., Walsh T.S., et al. Identification and proteomic profiling of exosomes in human cerebrospinal fluid. Journal of Translational Medicine 2012, 10:5.
66. Little K.M., Smalley D.M., Harthun N.L., Ley K. The plasma microparticle proteome. Seminars in Thrombosis and Hemostasis 2010, 36:845-856.
67. Ostergaard O., Nielsen C.T., Iversen L.V., Jacobsen S., Tanassi J.T., Heegaard N.H. Quantitative proteome profiling of normal human circulating microparticles. Journal of Proteome Research 2012, 11:2154-2163.
68. Bastos-Amador P., Royo F., Gonzalez E., Conde-Vancells J., Palomo-Diez L., Borras F.E., et al. Proteomic analysis of microvesicles from plasma of healthy donors reveals high individual variability. Journal of Proteomics 2012, 75:3574-3584.
69. Carayon K., Chaoui K., Ronzier E., Lazar I., Bertrand-Michel J., Roques V., et al. Proteolipidic composition of exosomes changes during reticulocyte maturation. Journal of Biological Chemistry 2011, 286:34426-34439.
70. Bosman G.J., Willekens F.L., Werre J.M. Erythrocyte aging: a more than superficial resemblance to apoptosis?. Cellular Physiology and Biochemistry 2005, 16:1-8.
71. Bosman G.J., Lasonder E., Luten M., Roerdinkholder-Stoelwinder B., Novotny V.M., Bos H., et al. The proteome of red cell membranes and vesicles during storage in blood bank conditions. Transfusion 2008, 48:827-835.
72. Bosman G.J., Lasonder E., Groenen-Dopp Y.A., Willekens F.L., Werre J.M., Novotny V.M. Comparative proteomics of erythrocyte aging in vivo and in vitro. Journal of Proteomics 2010, 73:396-402.
73. Kriebardis A.G., Antonelou M.H., Stamoulis K.E., Economou-Petersen E., Margaritis L.H., Papassideri I.S. RBC-derived vesicles during storage: ultrastructure, protein composition, oxidation, and signaling components. Transfusion 2008, 48:1943-1953.
74. Rubin O., Crettaz D., Canellini G., Tissot J.D., Lion N. Microparticles in stored red blood cells: an approach using flow cytometry and proteomic tools. Vox Sanguinis 2008, 95:288-297.
75. Delobel J., Prudent M., Rubin O., Crettaz D., Tissot J.D., Lion N. Subcellular fractionation of stored red blood cells reveals a compartment-based protein carbonylation evolution. Journal of Proteomics 2012, 76. [Spec No.: 181-93].
76. Dinkla S., Novotny V.M., Joosten I., Bosman G.J. Storage-induced changes in erythrocyte membrane proteins promote recognition by autoantibodies. PLoS ONE 2012, 7:e42250.
77. Almizraq R., Tchir J.D., Holovati J.L., Acker JP Storage of red blood cells affects membrane composition, microvesiculation, and in vitro quality. Transfusion 2013, [in press].
78. Chaichompoo P., Kumya P., Khowawisetsut L., Chiangjong W., Chaiyarit S., Pongsakul N., et al. Characterizations and proteome analysis of platelet-free plasma-derived microparticles in beta-thalassemia/hemoglobin E patients. Journal of Proteomics 2012, 76. [Spec No.: 239-50].
79. Di Michele M., Van Geet C., Freson K. Recent advances in platelet proteomics. Expert Review of Proteomics 2012, 9:451-466.
80. Zufferey A., Fontana P., Reny J.L., Nolli S., Sanchez J.C. Platelet proteomics. Mass Spectrometry Reviews 2012, 31:331-351.
81. Senis Y., Garcia A. Platelet proteomics: state of the art and future perspective. Methods in Molecular Biology 2012, 788:367-399.
82. Senzel L., Gnatenko D.V., Bahou W.F. The platelet proteome. Current Opinion in Hematology 2009, 16:329-333.
83. Greening D.W., Glenister K.M., Sparrow R.L., Simpson R.J. Enrichment of human platelet membranes for proteomic analysis. Methods in Molecular Biology 2009, 528:245-258.
84. Premsler T., Lewandrowski U., Sickmann A., Zahedi R.P. Phosphoproteome analysis of the platelet plasma membrane. Methods in Molecular Biology 2011, 728:279-290.
85. Wright B., Stanley R.G., Kaiser W.J., Gibbins J.M. The integration of proteomics and systems approaches to map regulatory mechanisms underpinning platelet function. Proteomics. Clinical Applications 2013, 7:144-154.
86. Garcia B.A., Smalley D.M., Cho H., Shabanowitz J., Ley K., Hunt D.F. The platelet microparticle proteome. Journal of Proteome Research 2005, 4:1516-1521.
87. Jin M., Drwal G., Bourgeois T., Saltz J., Wu H.M. Distinct proteome features of plasma microparticles. Proteomics 2005, 5:1940-1952.
88. Dean W.L., Lee M.J., Cummins T.D., Schultz D.J., Powell D.W. Proteomic and functional characterisation of platelet microparticle size classes. Thrombosis and Haemostasis 2009, 102:711-718.
89. Wubbolts R., Leckie R.S., Veenhuizen P.T., Schwarzmann G., Mobius W., Hoernschemeyer J., et al. Proteomic and biochemical analyses of human B cell-derived exosomes. Potential implications for their function and multivesicular body formation. Journal of Biological Chemistry 2003, 278:10963-10972.
90. Miguet L., Pacaud K., Felden C., Hugel B., Martinez M.C., Freyssinet J.M., et al. Proteomic analysis of malignant lymphocyte membrane microparticles using double ionization coverage optimization. Proteomics 2005, 6:153-171.
91. Miguet L., Bechade G., Fornecker L., Zink E., Felden C., Gervais C., et al. Proteomic analysis of malignant B-cell derived microparticles reveals CD148 as a potentially useful antigenic biomarker for mantle cell lymphoma diagnosis. Journal of Proteome Research 2009, 8:3346-3354.
92. Banfi C., Brioschi M., Wait R., Begum S., Gianazza E., Pirillo A., et al. Proteome of endothelial cell-derived procoagulant microparticles. Proteomics 2005, 5:4443-4455.
93. Liu Y., Huang W., Zhang R., Wu J., Li L., Tang Y. Proteomic analysis of TNF-alpha-activated endothelial cells and endothelial microparticles. Molecular Medicine Reports 2012.
94. Lacroix R., Plawinski L., Robert S., Doeuvre L., Sabatier F., Martinez de Lizarrondo S., et al. Leukocyte- and endothelial-derived microparticles: a circulating source for fibrinolysis. Haematologica 2012, 97:1864-1872.
95. Kabaso D., Shlomovitz R., Schloen K., Stradal T., Gov N.S. Theoretical model for cellular shapes driven by protrusive and adhesive forces. PLoS Computational Biology 2011, 7:e1001127.
96. Gov N.S., Safran S.A. Red blood cell membrane fluctuations and shape controlled by ATP-induced cytoskeletal defects. Biophysical Journal 2005, 88:1859-1874.
97. Park Y., Best C.A., Auth T., Gov N.S., Safran S.A., Popescu G., et al. Metabolic remodeling of the human red blood cell membrane. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:1289-1294.
98. Auth T., Safran S.A., Gov N.S. Fluctuations of coupled fluid and solid membranes with application to red blood cells. Physical Review E: Statistical, Nonlinear, and Soft Matter Physics 2007, 76:051910.
99. Burnier L., Fontana P., Kwak B.R., Angelillo-Scherrer A. Cell-derived microparticles in haemostasis and vascular medicine. Thrombosis and Haemostasis 2009, 101:439-451.
100. Foller M., Huber S.M., Lang F. Erythrocyte programmed cell death. IUBMB Life 2008, 60:661-668.
101. Iida K., Whitlow M.B., Nussenzweig V. Membrane vesiculation protects erythrocytes from destruction by complement. Journal of Immunology 1991, 147:2638-2642.
102. Willekens F.L., Werre J.M., Kruijt J.K., Roerdinkholder-Stoelwinder B., Groenen-Dopp Y.A., van den Bos A.G., et al. Liver Kupffer cells rapidly remove red blood cell-derived vesicles from the circulation by scavenger receptors. Blood 2005, 105:2141-2145.
103. Willekens F.L., Werre J.M., Groenen-Dopp Y.A., Roerdinkholder-Stoelwinder B., de Pauw B., Bosman G.J. Erythrocyte vesiculation: a self-protective mechanism?. British Journal of Haematology 2008, 141:549-556.
104. Stewart A., Urbaniak S., Turner M., Bessos H. The application of a new quantitative assay for the monitoring of integrin-associated protein CD47 on red blood cells during storage and comparison with the expression of CD47 and phosphatidylserine with flow cytometry. Transfusion 2005, 45:1496-1503.
105. Oldenborg P.A. Role of CD47 and signaling protein alpha (SIRPα) in regulating the clearence of viable or aged blood cells. Transfusion Medicine and Hemotherapy 2012, 39:315-320.
106. Burger P., de Korte D., van den Berg T.K., van Bruggen R. CD47 in erythrocyte ageing and clearence - the Dutch point of view. Transfusion Medicine and Hemotherapy 2012, 39:348-352.
107. Low P.S., Willardson B.M., Mohandas N., Rossi M., Shohet S. Contribution of the band 3-ankyrin interaction to erythrocyte membrane mechanical stability. Blood 1991, 77:1581-1586.
108. Lang F., Gulbins E., Lerche H., Huber S.M., Kempe D.S., Foller M. Eryptosis, a window to systemic disease. Cellular Physiology and Biochemistry 2008, 22:373-380.
109. Mannu F., Arese P., Cappellini M.D., Fiorelli G., Cappadoro M., Giribaldi G., et al. Role of hemichrome binding to erythrocyte membrane in the generation of band-3 alterations in beta-thalassemia intermedia erythrocytes. Blood 1995, 86:2014-2020.
110. Arese P., Turrini F., Schwarzer E. Band 3/complement-mediated recognition and removal of normally senescent and pathological human erythrocytes. Cellular Physiology and Biochemistry 2005, 16:133-146.
111. Stowell S.R., Smith N.H., Zimring J.C., Fu X., Palmer A.F., Fontes J., et al. Addition of ascorbic acid solution to stored murine red blood cells increases posttransfusion recovery and decreases microparticles and alloimmunization. Transfusion 2013, [in press].
112. Dumaswala U.J., Wilson M.J., Wu Y.L., Wykle J., Zhuo L., Douglass L.M., et al. Glutathione loading prevents free radical injury in red blood cells after storage. Free Radical Research 2000, 33:517-529.
113. D'Alessandro A., Gevi F., Zolla L. Red blood cell metabolism under prolonged anaerobic storage. Molecular Biosystems 2013, [in press].
114. Marrocco C., Pallotta V., D'Alessandro A., Alves G., Zolla L. Red blood cell populations and membrane levels of peroxiredoxin 2 as candidate biomarkers to reveal blood doping. Blood Transfusion 2012, 10(Suppl. 2):s71-s77.
115. D'Amici G.M., Mirasole C., D'Alessandro A., Yoshida T., Dumont L.J., Zolla L. Red blood cell storage in SAGM and AS3: a comparison through the membrane two-dimensional electrophoresis proteome. Blood Transfusion 2012, 10(Suppl. 2):s46-s54.
116. D'Alessandro A., Giardina B., Gevi F., Timperio A.M., Zolla L. Clinical metabolomics: the next stage of clinical biochemistry. Blood Transfusion 2012, 10(Suppl. 2):s19-s24.
117. Antonelou M.H., Tzounakas V.L., Velentzas A.D., Stamoulis K.E., Kriebardis A.G., Papassideri I.S. Effects of pre-storage leukoreduction on stored red blood cells signaling: a time-course evaluation from shape to proteome. Journal of Proteomics 2012, 76. Spec No. [220-38].
118. Gevi F., D'Alessandro A., Rinalducci S., Zolla L. Alterations of red blood cell metabolome during cold liquid storage of erythrocyte concentrates in CPD-SAGM. Journal of Proteomics 2012, 76. Spec No. [168-80].
119. 2+-ATPase by heparin is modulated by potassium. International Journal of Biochemistry and Cell Biology 2007, 39:586-596.
120. Pompeo G., Girasole M., Cricenti A., Boumis G., Bellelli A., Amiconi S. Erythrocyte death in vitro induced by starvation in the absence of Ca(2+). Biochimica et Biophysica Acta 2010, 1798:1047-1055.
121. Bosman G.J. Erythrocyte aging in sickle cell disease. Cellular and Molecular Biology 2004, 50:81-86.
122. van Beers E.J., Schaap M.C., Berckmans R.J., Nieuwland R., Sturk A., van Doormaal F.F., et al. Circulating erythrocyte-derived microparticles are associated with coagulation activation in sickle cell disease. Haematologica 2009, 94:1513-1519.
123. Westerman M., Pizzey A., Hirschman J., Cerino M., Weil-Weiner Y., Ramotar P., et al. Microvesicles in haemoglobinopathies offer insights into mechanisms of hypercoagulability, haemolysis and the effects of therapy. British Journal of Haematology 2008, 142:126-135.
124. Tantawy A.A., Adly A.A., Ismail E.A., Habeeb N.M., Farouk A. Circulating platelet and erythrocyte microparticles in young children and adolescents with sickle cell disease: relation to cardiovascular complications. Platelets 2012.
125. Setty B.N., Rao A.K., Stuart M.J. Thrombophilia in sickle cell disease: the red cell connection. Blood 2001, 98:3228-3233.
126. Horne M.K., Cullinane A.M., Merryman P.K., Hoddeson E.K. The effect of red blood cells on thrombin generation. British Journal of Haematology 2006, 133:403-408.
127. Van Der Meijden P.E., Van Schilfgaarde M., Van Oerle R., Renne T., ten Cate H., Spronk H.M. Platelet- and erythrocyte-derived microparticles trigger thrombin generation via factor XIIa. Journal of Thrombosis and Haemostasis 2012, 10:1355-1362.
128. Ninomiya H., Kawashima Y., Hasegawa Y., Nagasawa T. Complement-induced procoagulant alteration of red blood cell membranes with microvesicle formation in paroxysmal nocturnal haemoglobinuria (PNH): implication for thrombogenesis in PNH. British Journal of Haematology 1999, 106:224-231.
129. Whitlow M., Iida K., Marshall P., Silber R., Nussenzweig V. Cells lacking glycan phosphatidylinositol-linked proteins have impaired ability to vesiculate. Blood 1993, 81:510-516.
130. Kozuma Y., Sawahata Y., Takei Y., Chiba S., Ninomiya H. Procoagulant properties of microparticles released from red blood cells in paroxysmal nocturnal haemoglobinuria. British Journal of Haematology 2011, 152:631-639.
131. Rank A., Nieuwland R., Toth B., Pihusch V., Delker R., Hiller E., et al. Microparticles for diagnosis of graft-versus-host disease after allogeneic stem cell transplantation. Transplantation 2011, 92:244-250.
132. Reid V.L., Webster N.R. Role of microparticles in sepsis. British Journal of Anaesthesia 2012, 109:503-513.
133. Delabranche X., Berger A., Boisrame-Helms J., Meziani F. Microparticles and infectious diseases. Médecine et Maladies Infectieuses 2012, 42:335-343.
134. Campos F.M., Franklin B.S., Teixeira-Carvalho A., Filho A.L., de Paula S.C., Fontes C.J., et al. Augmented plasma microparticles during acute Plasmodium vivax infection. Malaria Journal 2010, 9:327.
135. D'Alessandro A., D'Amici G.M., Vaglio S., Zolla L. Time-course investigation of SAGM-stored leukocyte-filtered red bood cell concentrates: from metabolism to proteomics. Haematologica 2012, 97:107-115.
136. Thon J.N., Italiano J.E. Does size matter in platelet production?. Blood 2012, 120:1552-1561.
137. Chen K., Rondina M.T., Weyrich A.S. A sticky story for STAT3 in platelets. Circulation 2013, 127:421-423.
138. Siljander P.R. Platelet-derived microparticles - an updated perspective. Thrombosis Research 2011, 127(Suppl. 2):S30-S33.
139. Varon D., Shai E. Role of platelet-derived microparticles in angiogenesis and tumor progression. Discovery Medicine 2009, 8:237-241.
140. Mullier F., Bailly N., Cornet Y., Dubuc E., Robert S., Osselaer J.C., et al. Contribution of platelet microparticles generation assay to the diagnosis of type II heparin-induced thrombocytopenia. Thrombosis and Haemostasis 2010, 103:1277-1281.
141. Aatonen M., Gronholm M., Siljander P.R. Platelet-derived microvesicles: multitalented participants in intercellular communication. Seminars in Thrombosis and Hemostasis 2012, 38:102-113.
142. Suades R., Padro T., Vilahur G., Badimon L. Circulating and platelet-derived microparticles in human blood enhance thrombosis on atherosclerotic plaques. Thrombosis and Haemostasis 2012, 108:1208-1219.
143. Boilard E., Blanco P., Nigrovic P.A., Platelets: active players in the pathogenesis of arthritis and SLE. Nature Reviews Rheumatology 2012, 8:534-542.
144. Varon D., Hayon Y., Dashevsky O., Shai E. Involvement of platelet derived microparticles in tumor metastasis and tissue regeneration. Thrombosis Research 2012, 130(Suppl 1):S98-S99.
145. Mause S.F. Platelet microparticles: reinforcing the hegemony of platelets in atherothrombosis. Thrombosis and Haemostasis 2012, 109.
146. Nollet K.E., Saito S., Ono T., Ngoma A., Ohto H. Microparticle formation in apheresis platelets is not affected by three leukoreduction filters. Transfusion 2013.
147. Hayon Y., Shai E., Varon D., Leker R.R. The role of platelets and their microparticles in rehabilitation of ischemic brain tissue. CNS & Neurological Disorders Drug Targets 2012, 11:921-925.
148. Angelillo-Scherrer A. Leukocyte-derived microparticles in vascular homeostasis. Circulation Research 2012, 110:356-369.
149. Eken C., Gasser O., Zenhaeusern G., Oehri I., Hess C., Schifferli J.A. Polymorphonuclear neutrophil-derived ectosomes interfere with the maturation of monocyte-derived dendritic cells. Journal of Immunology 2008, 180:817-824.
150. Eken C., Sadallah S., Martin P.J., Treves S., Schifferli J.A. Ectosomes of polymorphonuclear neutrophils activate multiple signaling pathways in macrophages. Immunobiology 2013, 218:382-392.
151. Lacroix R., Dignat-George F., Microparticles: new protagonists in pericellular and intravascular proteolysis. Seminars in Thrombosis and Hemostasis 2013, 39:33-39.
152. Ghosh A.K., Secreto C.R., Knox T.R., Ding W., Mukhopadhyay D., Kay N.E. Circulating microvesicles in B-cell chronic lymphocytic leukemia can stimulate marrow stromal cells: implications for disease progression. Blood 2010, 115:1755-1764.
153. Savasan S., Buyukavci M., Buck S., Ravindranath Y. Leukaemia/lymphoma cell microparticles in childhood mature B cell neoplasms. Journal of Clinical Pathology 2004, 57:651-653.
154. Kwaan H.C., Rego E.M. Role of microparticles in the hemostatic dysfunction in acute promyelocytic leukemia. Seminars in Thrombosis and Hemostasis 2010, 36:917-924.
155. Van Aalderen M.C., Trappenburg M.C., Van Schilfgaarde M., Molenaar P.J., Ten Cate H., Terpstra W.E., et al. Procoagulant myeloblast-derived microparticles in AML patients: changes in numbers and thrombin generation potential during chemotherapy. Journal of Thrombosis and Haemostasis 2011, 9:223-226.
156. Ma G., Liu F., Lv L., Gao Y., Su Y. Increased promyelocytic-derived microparticles: a novel potential factor for coagulopathy in acute promyelocytic leukemia. Annals of Hematology 2013, 92:645-652.
157. Sabatier F., Camoin-Jau L., Anfosso F., Sampol J., Dignat-George F. Circulating endothelial cells, microparticles and progenitors: key players towards the definition of vascular competence. Journal of Cellular and Molecular Medicine 2009, 13:454-471.
158. Yong P.J., Koh C.H., Shim W. Endothelial microparticles: missing link in endothelial dysfunction?. European Journal of Preventive Cardiology 2013, 20:496-512.
159. Burger D., Kwart D.G., Montezano A.C., Read N.C., Kennedy C.R., Thompson C.S., et al. Microparticles induce cell cycle arrest through redox-sensitive processes in endothelial cells: implications in vascular senescence. Journal of the American Heart Association 2012, 1:e001842.
160. Petrozella L., Mahendroo M., Timmons B., Roberts S., McIntire D., Alexander J.M. Endothelial microparticles and the antiangiogenic state in preeclampsia and the postpartum period. American Journal of Obstetrics and Gynecology 2012, 207(140):e20-e26.
161. Amabile N., Guignabert C., Montani D., Yeghiazarians Y., Boulanger C.M., Humbert M Cellular microparticles in the pathogenesis of pulmonary hypertension. European Respiratory Journal 2013, [in press].
162. Wu Q., Chen H., Fang J., Xie W., Hong M., Xia L. Elevated Fas/FasL system and endothelial cell microparticles are involved in endothelial damage in acute graft-versus-host disease: a clinical analysis. Leukemia Research 2012, 36:275-280.
163. Pericleous C., Clarke L.A., Brogan P.A., Latchman D.S., Isenberg D.A., Ioannou Y., et al. Endothelial microparticle release is stimulated in vitro by purified IgG from patients with the antiphospholipid syndrome. Thrombosis and Haemostasis 2013, 109:72-78.
164. Tan Z., Yuan Y., Chen S., Chen Y., Chen TX Elevated plasma endothelial microparticles together with TNF-alpha and IL-6 in Kawasaki disease. Indian Pediatrics 2013, [in press].
165. Fleitas T., Martinez-Sales V., Vila V., Reganon E., Mesado D., Martin M., et al. Circulating endothelial cells and microparticles as prognostic markers in advanced non-small cell lung cancer. PLoS ONE 2012, 7:e47365.
166. Ci H.B., Ou Z.J., Chang F.J., Liu D.H., He G.W., Xu Z., et al. Endothelial microparticles increase in mitral valve disease and impair mitral valve endothelial function. American Journal of Physiology - Endocrinology and Metabolism 2013, 304:e695-e702.
167. Alkhatatbeh M.J., Enjeti A.K., Acharya S., Thorne R.F., Lincz L.F. The origin of circulating CD36 in type 2 diabetes. Nutrition & Diabetes 2013, 3:e59.